235 related articles for article (PubMed ID: 9489743)
1. [3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies.
Fredholm BB; Lindström K; Dionisotti S; Ongini E
J Neurochem; 1998 Mar; 70(3):1210-6. PubMed ID: 9489743
[TBL] [Abstract][Full Text] [Related]
2. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
[TBL] [Abstract][Full Text] [Related]
3. The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain.
Lindström K; Ongini E; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):539-41. PubMed ID: 8897460
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
5. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
Cunha RA; Constantino MD; Ribeiro JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
[TBL] [Abstract][Full Text] [Related]
6. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors.
Johansson B; Georgiev V; Fredholm BB
Neuroscience; 1997 Oct; 80(4):1187-207. PubMed ID: 9284070
[TBL] [Abstract][Full Text] [Related]
7. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
8. Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography.
Johansson B; Fredholm BB
Neuropharmacology; 1995 Apr; 34(4):393-403. PubMed ID: 7566470
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
Fredholm BB; Lindström K
Eur J Pharmacol; 1999 Sep; 380(2-3):197-202. PubMed ID: 10513579
[TBL] [Abstract][Full Text] [Related]
10. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
Ongini E; Dionisotti S; Gessi S; Irenius E; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):7-10. PubMed ID: 9933143
[TBL] [Abstract][Full Text] [Related]
12. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
13. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
[TBL] [Abstract][Full Text] [Related]
14. Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes.
Marchi M; Raiteri L; Risso F; Vallarino A; Bonfanti A; Monopoli A; Ongini E; Raiteri M
Br J Pharmacol; 2002 Jun; 136(3):434-40. PubMed ID: 12023946
[TBL] [Abstract][Full Text] [Related]
15. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
Kirk IP; Richardson PJ
Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
[TBL] [Abstract][Full Text] [Related]
16. In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261.
El Yacoubi M; Ledent C; Parmentier M; Ongini E; Costentin J; Vaugeois JM
Eur J Neurosci; 2001 Nov; 14(9):1567-70. PubMed ID: 11722618
[TBL] [Abstract][Full Text] [Related]
17. Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes.
Belardinelli L; Shryock JC; Ruble J; Monopoli A; Dionisotti S; Ongini E; Dennis DM; Baker SP
Circ Res; 1996 Dec; 79(6):1153-60. PubMed ID: 8943953
[TBL] [Abstract][Full Text] [Related]
18. Role of cysteine residues of rat A2a adenosine receptors in agonist binding.
Mazzoni MR; Giusti L; Rossi E; Taddei S; Lucacchini A
Biochim Biophys Acta; 1997 Feb; 1324(1):159-70. PubMed ID: 9059509
[TBL] [Abstract][Full Text] [Related]
19. Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives.
Gao ZG; Kim SG; Soltysiak KA; Melman N; IJzerman AP; Jacobson KA
Mol Pharmacol; 2002 Jul; 62(1):81-9. PubMed ID: 12065758
[TBL] [Abstract][Full Text] [Related]
20. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
Rivkees SA; Lasbury ME; Barbhaiya H
J Biol Chem; 1995 Sep; 270(35):20485-90. PubMed ID: 7657625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
